Motiva??o de jovens e adultos para o treinamento do atletismo.

O estudo investigou diferen?as na motiva??o de atletas do atletismo, comparando grupos de provas, n?vel competitivo, categoria e sexo. Avaliamos a motiva??o atrav?s do question?rio (SMS-BR28) de 133 atletas, 56% do sexo masculino e 44% do sexo feminino. N?o teve diferen?as significativas entre grupos de provas e n?vel competitivo, n?vel de signific?ncia (P<0,05). Houve diferen?a significativa comparando ? motiva??o de juvenis e adultos vs pr?-mirim e mirim. Conclu?mos que a motiva??o para treinar Atletismo independe da prova disputada, atletas juvenis, sub-23 e adultos s?o mais motivados intrinsecamente que os atletas pr?-mirim e mirim, em rela??o ao sexo os homens tem maior motiva??o extr?nseca que as mulheres

Effects of aflatoxin B1 on performance and health of tambaqui fingerlings (Colossoma macropomum)

Abstract The detection of mycotoxins in feeds and their ingredients in aquaculture gained prominence due to losses caused in production and animal health, mainly the occurrence of aflatoxin (AFB1). The aim of this study was to evaluate the effects of AFB1 on the performance of tambaqui fingerlings (Colossoma macropomum). Four hundred tambaqui were used. Four different treatments were evaluated: treatment T1, considered as the control treatment (CT) with 3.84 μg kg−1; treatment T2, treatment T3 and treatment T4 with 500, 1000 and 2000 μg kg−1 of AFB1, respectively. The AFB1 of the samples (muscle, liver and kidney) was detected by high-pressure liquid chromatography. Four fingerlings from each treatment for histological analysis were examined. Moreover, the performance parameters (weight gain, feed conversion and feed intake) were studied. The levels of toxins used in T2, T3 and T4 represent a reduction in the growth of 14%, 35% and 45%, respectively. The T3 and T4 showed the lowest weight gain (78%) and the worst feed conversion. Aflatoxin B1 in muscle (3.28 μg kg−1) and kidneys (8.8 μg kg−1) in the T3, as well as liver (4.4 μg kg−1) and kidney (4.08 μg kg−1) in T4, was detected. Histopathological changes in liver and kidney tissues of fingerlings were more pronounced in T3 and T4. Fingerlings that consume feed contaminated with AFB1 in concentrations higher than 500 μg kg−1 present decreases in growth, reduction in weight gain and feed intake with increased feed conversion. The consumption of feed contaminated with 1000 and 2000 μg kg−1 of AFB1 caused severe deterioration in the hepatic and renal tissues

Harnessing a Physiologic Mechanism for siRNA Delivery With Mimetic Lipoprotein Particles

Therapeutics based on RNA interference (RNAi) have emerged as a potential new class of drugs for treating human disease by silencing the target messenger RNA (mRNA), thereby reducing levels of the corresponding pathogenic protein. The major challenge for RNAi therapeutics is the development of safe delivery vehicles for small interfering RNAs (siRNAs). We previously showed that cholesterol-conjugated siRNAs (chol-siRNA) associate with plasma lipoprotein particles and distribute primarily to the liver after systemic administration to mice. We further demonstrated enhancement of silencing by administration of chol-siRNA pre-associated with isolated high-density lipoprotein (HDL) or low-density lipoprotein (LDL). In this study, we investigated mimetic lipoprotein particle prepared from recombinant apolipoprotein A1 (apoA) and apolipoprotein E3 (apoE) as a delivery vehicle for chol-siRNAs. We show that apoE-containing particle (E-lip) is highly effective in functional delivery of chol-siRNA to mouse liver. E-lip delivery was found to be considerably more potent than apoA-containing particle (A-lip). Furthermore, E-lip–mediated delivery was not significantly affected by high endogenous levels of plasma LDL. These results demonstrate that E-lip has substantial potential as delivery vehicles for lipophilic conjugates of siRNAs.ISSN:1525-0016ISSN:1525-002